US regulators to weigh controversial peptides backed by RFK Jr

July 23, 2026 - 03:37

U.S. regulators are preparing to evaluate a class of controversial peptides that have gained a passionate following, partly due to endorsements from Robert F. Kennedy Jr. The compounds, often sold as treatments for sleep disorders, muscle recovery, and anti-aging, have seen a surge in demand despite a lack of solid scientific backing.

The Food and Drug Administration has publicly questioned the evidence behind these products. Many are marketed as dietary supplements or research chemicals, allowing them to bypass the rigorous clinical trials required for prescription drugs. This loophole has led to a booming online market where consumers can buy injectable peptides without a prescription.

Kennedy, a prominent vaccine skeptic and environmental lawyer, has promoted these peptides as alternatives to mainstream medicine. His advocacy has fueled interest among wellness enthusiasts and biohackers looking for quick fixes for fatigue or aging. However, medical experts warn that the long-term safety and effectiveness of these compounds remain unknown.

The FDA now faces pressure to clarify its stance. Some lawmakers and health groups want stricter enforcement against unapproved marketing, while proponents argue that peptides offer a natural way to boost health. The agency has not announced a timeline for its review, but the debate highlights the growing tension between consumer demand for alternative therapies and the need for scientific oversight.